SCHEMBL10187456

SCHEMBL10187456

Cc1cccc(Oc2ccc(S)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ HTT P42858 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ ACHE P22303 1/20 0.52
▸ HSD17B1 P14061 1/20 0.49
▸ HSD17B2 P37059 1/20 0.49
▸ AR P10275 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ GFER P55789 3/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ MITF O75030 1/20 0.45
▸ NLRP1 Q9C000 1/20 0.45
▸ NOD2 Q9HC29 1/20 0.45
▸ LYN P07948 1/20 0.45
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10013917 0.89 ALDH1A1 (0.80) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL14159539 0.89 ALDH1A1 (0.80) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL30195024 0.85 ALDH1A1 (0.74) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL822034 0.85 ALDH1A1 (0.74) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL822088 0.85 ALDH1A1 (0.74) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL27090239 0.85 SMN1; SMN2 (0.60) ALDH1A1TDP1GAAGFERSMN1; SMN2
SCHEMBL29746015 0.85 ALDH1A1 (0.72) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL29398372 0.85 ALDH1A1 (0.72) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL456868 0.85 ALDH1A1 (0.72) ALDH1A1L3MBTL1HTTTDP1ACHE
SCHEMBL675770 0.83 ALDH1A1 (0.71) ALDH1A1L3MBTL1HTTTDP1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093287-B2 Inhibitors of matrix metalloproteinases UNIVERSITY OF NOTRE DAME DU LAC (US) 2012-01-10 — — US disclosed
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES NOTRE DAME UNIVERSITY (US) 2011-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES MMP9, MMP1, MMP2 ALDH1A1 403/4885L3MBTL1 4619/4885HTT 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback